Final Programme

Saturday,
April 1, 2006
Sunday,
April 2, 2006
Scientific Programme Overview
10
11
12
13
14
15
16
17
18
19
07
08
09
10
11
12
13
14
15
16
17
18
page 2 Final Programme
Apollon Athena Méditerranée 1 Méditerranée 2 Méditerranée 3 Iris
13.30 – 15.30
13.30 – 15.30
13.30 – 15.30
13.30 – 15.30
13.30 – 15.30
Practical and
theoretical aspects of
sequence-based
typing: the paradigms
of S. aureus
and S. pyogenes
ESGEM Work -
shop p.27
Quality control
and
standardisa tion
in molecular
diagnostics
ESGMD Work -
shop p.27
Management of Current control
nosocomial measures for
infections – Toxoplasma
learning from infection in preg-
clinical cases nant women and
new-born children
ESGNI Work - ESGT Work -
shop p.27 shop p.27
Antibiotic
resistance
of microbial
biofilms
ESGB Workshop
p.29
15.30 – 17.30
Evidence and ex- 15.45 – 16.45
15.45 – 16.45
perience: the role Dendograms in Antimicrobial resis -
microbial phylogene- tance in anaerobic
of echinocandins
tics and epidemio - bacteria. Experiences
in the manage- lo gical typing in Europe and USA
p.31
p.31
ment of invasive
16.45 – 17.45
16.45 – 17.45
fungal infections
ESGEM ESGARAB
MSD p.31 Meeting Meeting
p.26
p.26
15.45 – 17.15
Pathogenesis
and prevention
of nosocomial
infections –
new aspects
p.31
17.15 – 17.45
ESGNI Meeting
15.45 – 16.45
15.45 – 17.15
News in the How to prevent
field of toxo- microbial biofilm
plasmosisp.32
formation on
16.45 – 17.45 medical devices
ESGT
p.32
Meeting
17.15 – 17.45
p.26 ESGB Meeting
18.00 – 21.00
Opening
Ceremony
&
Welcome
Reception
p.26
p.26
Apollon Athena Méditerranée 1 Méditerranée 2 Méditerranée 3 Iris
07.15 – 08.15
07.15 – 08.15
07.15 – 08.15
Lab diagnosis of Current issues in What is the role
invasive fungal the treatment of of serology in
HBV-HIV co-infected
infections
patients
pregnancy?
p.33 p.33 p.33
08.30 – 10.30
08.30 – 10.30
08.30 – 10.30
08.30 – 10.30
08.30 – 10.30
08.30 – 10.30
New diagnostic Tailoring initial The challenge for Neurological Quinolone Viruses and
techniques antifungal antibiotic therapy sequelae of resistance and viral
for the
therapy in treating bacterial and efflux diagnostics
microbiology according to complicated viral infections
laboratory and epidemiological infections: how
general
trends broad is enough?
practitioner Schering-Plough
p.34 p.37 MSD p.37 p.34 p.34 p.35
11.00 – 12.00
ESCMID
Excellence
Award Lecture
11.00 – 12.00
Impact of microbial
genomics on
epidemiology and
control of ID
Poster Session I: 12.00–13.00
Poster Session II: 13.00–14.00
Poster Walks
14.00 – 15.00
14.00 – 15.00
14.00 – 15.00
14.00 – 15.00
14.00 – 15.00
14.00 – 15.00
The year in Is microbiological The hyper-virulent Dissemination
infectious work-up in community- strain of C. difficile: of molecular
diseases medicine acquired pneumonia sharing experiences in resistance traits
p.41 still useful? p.41 Europe and USAp.41
p.41
Diabetes and
infection
p.42
Pump it out
and resist
p.42
15.30 – 17.30
15.30 – 17.30
15.30 – 17.30
15.30 – 17.30
15.30 – 17.30
15.30 – 17.30
Current Readdressing the Addressing
aspects on importance of macrolide issues
MRSA Gram-negative re- in communitysistance:pathoacquired
RTI
gens, practice
patterns, and
pharmacotherapy
p.43 Wyeth p.45 Pfizer p.46
Mechanisms
of infectious
diseases:
new science
and
novel
insights
p.43
Antimicrobial
clinical trials
p.43
Epidemic
influenza
p.44
17.45 – 18.45
Late breaker
Session on
Avian influenza
p.46
p.38 p.38